Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 5.80 · gapped above the open, then crossed back over prior close. High/low 5.95 at 4:30 am ET, 5.71 at 10:45 am ET.
Opus Genetics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
103 institutional managers report a position in Opus Genetics, Inc. worth $236.5M between them, filed on form 13F for the quarter ending 2026-06-30. 17 of them hold 80% of it, the largest being Caligan Partners LP at 10.56%.
78 more managers in the register
17 managers hold 80% of the $236.5M institutional base. The other 86 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
IRD (Opus Genetics, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Caligan Partners LP, Adage Capital Partners GP, L.L.C., Balyasny Asset Management LLC +3 more · 10.56% of IRD, 11.58% of SABS
via Caligan Partners LP, Nantahala Capital Management, LLC, Trails Edge Capital Partners, LP +5 more · 10.56% of IRD, 9.66% of IVA
via Balyasny Asset Management LLC, Caligan Partners LP, Trails Edge Capital Partners, LP +5 more · 5.37% of IRD, 7.41% of FTH
via Adage Capital Partners GP, L.L.C., Caligan Partners LP, Nantahala Capital Management, LLC +5 more · 10.48% of IRD, 4.86% of AURA
via Caligan Partners LP, Trails Edge Capital Partners, LP, Nantahala Capital Management, LLC +3 more · 10.56% of IRD, 4.83% of LBRX
via Balyasny Asset Management LLC, Caligan Partners LP, Great Point Partners LLC +3 more · 5.37% of IRD, 7.01% of SGMT
Managers holding a meaningful stake in IRD also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.